Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Functional annotation of risk loci identified through genome-wide association studies for prostate cancer.

Lu Y, Zhang Z, Yu H, Zheng SL, Isaacs WB, Xu J, Sun J.

Prostate. 2011 Jun 15;71(9):955-63. doi: 10.1002/pros.21311. Epub 2010 Dec 6.

2.

Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.

Lu Y, Sun J, Kader AK, Kim ST, Kim JW, Liu W, Sun J, Lu D, Feng J, Zhu Y, Jin T, Zhang Z, Dimitrov L, Lowey J, Campbell K, Suh E, Duggan D, Carpten J, Trent JM, Gronberg H, Zheng SL, Isaacs WB, Xu J.

Prostate. 2012 Mar;72(4):376-85. doi: 10.1002/pros.21439. Epub 2011 Jun 10.

3.

Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.

Chen H, Yu H, Wang J, Zhang Z, Gao Z, Chen Z, Lu Y, Liu W, Jiang D, Zheng SL, Wei GH, Issacs WB, Feng J, Xu J.

Prostate. 2015 Sep;75(12):1264-76. doi: 10.1002/pros.23008. Epub 2015 May 25. Review.

PMID:
26015065
4.

Post genome-wide association studies functional characterization of prostate cancer risk loci.

Jiang J, Cui W, Vongsangnak W, Hu G, Shen B.

BMC Genomics. 2013;14 Suppl 8:S9. doi: 10.1186/1471-2164-14-S8-S9. Epub 2013 Dec 9.

5.

A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.

Feng J, Sun J, Kim ST, Lu Y, Wang Z, Zhang Z, Gronberg H, Isaacs WB, Zheng SL, Xu J.

Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2396-403. doi: 10.1158/1055-9965.EPI-11-0523. Epub 2011 Sep 29.

6.

Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites.

Bu H, Narisu N, Schlick B, Rainer J, Manke T, Schäfer G, Pasqualini L, Chines P, Schweiger MR, Fuchsberger C, Klocker H.

Hum Mutat. 2016 Jan;37(1):52-64. doi: 10.1002/humu.22909. Epub 2015 Oct 19.

7.

Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.

Zhang X, Cowper-Sal lari R, Bailey SD, Moore JH, Lupien M.

Genome Res. 2012 Aug;22(8):1437-46. doi: 10.1101/gr.135665.111. Epub 2012 Jun 4.

8.

Comprehensive functional annotation of 77 prostate cancer risk loci.

Hazelett DJ, Rhie SK, Gaddis M, Yan C, Lakeland DL, Coetzee SG; Ellipse/GAME-ON consortium; Practical consortium, Henderson BE, Noushmehr H, Cozen W, Kote-Jarai Z, Eeles RA, Easton DF, Haiman CA, Lu W, Farnham PJ, Coetzee GA.

PLoS Genet. 2014 Jan 30;10(1):e1004102. doi: 10.1371/journal.pgen.1004102. eCollection 2014 Jan.

9.

Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.

Zuber V, Bettella F, Witoelar A; PRACTICAL Consortium; CRUK GWAS; BCAC Consortium; TRICL Consortium, Andreassen OA, Mills IG, Urbanucci A.

BMC Genomics. 2017 Mar 31;18(1):270. doi: 10.1186/s12864-017-3620-y.

10.

On the identification of potential regulatory variants within genome wide association candidate SNP sets.

Chen CY, Chang IS, Hsiung CA, Wasserman WW.

BMC Med Genomics. 2014 Jun 11;7:34. doi: 10.1186/1755-8794-7-34.

11.

Comprehensive functional annotation of seventy-one breast cancer risk Loci.

Rhie SK, Coetzee SG, Noushmehr H, Yan C, Kim JM, Haiman CA, Coetzee GA.

PLoS One. 2013 May 22;8(5):e63925. doi: 10.1371/journal.pone.0063925. Print 2013.

12.

Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk.

Jin G, Sun J, Isaacs SD, Wiley KE, Kim ST, Chu LW, Zhang Z, Zhao H, Zheng SL, Isaacs WB, Xu J.

Carcinogenesis. 2011 Nov;32(11):1655-9. doi: 10.1093/carcin/bgr187. Epub 2011 Aug 19.

13.

Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.

Jin HJ, Jung S, DebRoy AR, Davuluri RV.

Oncotarget. 2016 Aug 23;7(34):54616-54626. doi: 10.18632/oncotarget.10520.

14.

In-silico identification and functional validation of allele-dependent AR enhancers.

Garritano S, Romanel A, Ciribilli Y, Bisio A, Gavoci A, Inga A, Demichelis F.

Oncotarget. 2015 Mar 10;6(7):4816-28.

15.

Snat: a SNP annotation tool for bovine by integrating various sources of genomic information.

Jiang J, Jiang L, Zhou B, Fu W, Liu JF, Zhang Q.

BMC Genet. 2011 Oct 7;12:85. doi: 10.1186/1471-2156-12-85.

16.

A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.

Tao S, Wang Z, Feng J, Hsu FC, Jin G, Kim ST, Zhang Z, Gronberg H, Zheng LS, Isaacs WB, Xu J, Sun J.

Carcinogenesis. 2012 Mar;33(3):598-603. doi: 10.1093/carcin/bgr316. Epub 2012 Jan 4.

17.

SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies.

Xu Z, Taylor JA.

Nucleic Acids Res. 2009 Jul;37(Web Server issue):W600-5. doi: 10.1093/nar/gkp290. Epub 2009 May 5.

18.

A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.

Grill S, Fallah M, Leach RJ, Thompson IM, Hemminki K, Ankerst DP.

J Clin Epidemiol. 2015 May;68(5):563-73. doi: 10.1016/j.jclinepi.2015.01.006. Epub 2015 Jan 14.

PMID:
25684153
19.

Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.

Na R, Liu F, Zhang P, Ye D, Xu C, Shao Q, Qi J, Wang X, Chen Z, Wang M, He D, Wang Z, Zhou F, Yuan J, Gao X, Wei Q, Yang J, Jiao Y, Ou-Yang J, Zhu Y, Wu Q, Chen H, Lu D, Shi R, Lin X, Jiang H, Wang Z, Jiang D, Sun J, Zheng SL, Ding Q, Mo Z, Sun Y, Xu J.

Prostate. 2013 Nov;73(15):1623-35. doi: 10.1002/pros.22629. Epub 2013 Sep 9.

20.

Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.

Shan J, Al-Rumaihi K, Rabah D, Al-Bozom I, Kizhakayil D, Farhat K, Al-Said S, Kfoury H, Dsouza SP, Rowe J, Khalak HG, Jafri S, Aigha II, Chouchane L.

J Transl Med. 2013 May 13;11:121. doi: 10.1186/1479-5876-11-121.

Supplemental Content

Support Center